淋巴细胞-话题@MedSci

#淋巴细胞#

495篇内容 | 7101人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1302346, encodeId=948b130234697, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Br J Cancer：放疗前中性粒细胞淋巴细胞比值（NLR）：口咽癌患者的预后指标, objectType=article, longId=202445, objectId=02aa2024457d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02aa2024457d, replyNumber=0, likeNumber=69, createdTime=2020-10-25, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02aa2024457d, moduleTitle=Br J Cancer：放疗前中性粒细胞淋巴细胞比值（NLR）：口咽癌患者的预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02aa2024457d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302345, encodeId=d9c01302345db, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=达沙替尼-博纳吐单抗治疗成人ph+急性淋巴细胞白血病, objectType=article, longId=202422, objectId=f58020242298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f58020242298, replyNumber=0, likeNumber=53, createdTime=2020-10-25, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f58020242298, moduleTitle=达沙替尼-博纳吐单抗治疗成人ph+急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f58020242298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302344, encodeId=d941130234498, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=NEJM：达沙替尼-博纳吐单抗治疗费城染色体阳性急性淋巴细胞白血病, objectType=article, longId=202407, objectId=564a20240ecb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=564a20240ecb, replyNumber=0, likeNumber=112, createdTime=2020-10-24, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=564a20240ecb, moduleTitle=NEJM：达沙替尼-博纳吐单抗治疗费城染色体阳性急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=564a20240ecb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302343, encodeId=4441130234387, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=CD20单抗Ublituximab与PI3K抑制剂Umbralisib联合治疗慢性淋巴细胞白血病，获FDA快速通道指定, objectType=article, longId=202384, objectId=f40b202384ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f40b202384ce, replyNumber=0, likeNumber=0, createdTime=2020-10-24, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f40b202384ce, moduleTitle=CD20单抗Ublituximab与PI3K抑制剂Umbralisib联合治疗慢性淋巴细胞白血病，获FDA快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f40b202384ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302342, encodeId=4d3a13023424b, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：奥英妥珠单抗（InO）治疗儿童复发性/难治性CD22阳性急性淋巴细胞白血病, objectType=article, longId=202315, objectId=efc2202315cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efc2202315cb, replyNumber=0, likeNumber=73, createdTime=2020-10-22, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efc2202315cb, moduleTitle=Blood：奥英妥珠单抗（InO）治疗儿童复发性/难治性CD22阳性急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efc2202315cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302341, encodeId=b8fd130234174, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：急性淋巴细胞白血病婴儿的风险分层治疗, objectType=article, longId=202236, objectId=db7b2022363e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db7b2022363e, replyNumber=0, likeNumber=109, createdTime=2020-10-19, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db7b2022363e, moduleTitle=Blood：急性淋巴细胞白血病婴儿的风险分层治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db7b2022363e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302340, encodeId=b48d130234070, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Brit J Cancer：放疗前中性粒细胞与淋巴细胞比率对口咽癌患者的预后意义, objectType=article, longId=202127, objectId=ed8320212e75, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed8320212e75, replyNumber=0, likeNumber=80, createdTime=2020-10-16, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed8320212e75, moduleTitle=Brit J Cancer：放疗前中性粒细胞与淋巴细胞比率对口咽癌患者的预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed8320212e75)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302339, encodeId=62bf130233981, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：家族性B细胞前体-急性淋巴细胞白血病的胚系PAX5突变, objectType=article, longId=201968, objectId=46da2019686d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46da2019686d, replyNumber=0, likeNumber=66, createdTime=2020-10-12, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46da2019686d, moduleTitle=Blood：家族性B细胞前体-急性淋巴细胞白血病的胚系PAX5突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46da2019686d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302338, encodeId=51f1130233820, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：慢性淋巴细胞白血病刻板化亚型之间的高阶联系, objectType=article, longId=201682, objectId=c4a92016821f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4a92016821f, replyNumber=0, likeNumber=56, createdTime=2020-10-06, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4a92016821f, moduleTitle=Blood：慢性淋巴细胞白血病刻板化亚型之间的高阶联系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4a92016821f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302337, encodeId=afb7130233ee6, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=IBD:中性粒细胞与淋巴细胞之比和血小板与淋巴细胞之比可以预测溃疡性结肠炎患者接受抗TNF治疗后黏膜是否愈合, objectType=article, longId=201512, objectId=03352015129a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03352015129a, replyNumber=0, likeNumber=72, createdTime=2020-10-04, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03352015129a, moduleTitle=IBD:中性粒细胞与淋巴细胞之比和血小板与淋巴细胞之比可以预测溃疡性结肠炎患者接受抗TNF治疗后黏膜是否愈合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03352015129a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302336, encodeId=9834130233657, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=J Clin Oncol：优化成人急性淋巴细胞白血病患者的嵌合抗原受体T细胞治疗, objectType=article, longId=201430, objectId=394e2014304d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=394e2014304d, replyNumber=0, likeNumber=0, createdTime=2020-10-02, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=394e2014304d, moduleTitle=J Clin Oncol：优化成人急性淋巴细胞白血病患者的嵌合抗原受体T细胞治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=394e2014304d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302335, encodeId=5ba1130233516, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Eur J Pharmacol：miR-155的上调能够调控过敏性鼻炎中的第2组先天性淋巴细胞, objectType=article, longId=201369, objectId=5bb1201369aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bb1201369aa, replyNumber=0, likeNumber=59, createdTime=2020-09-30, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bb1201369aa, moduleTitle=Eur J Pharmacol：miR-155的上调能够调控过敏性鼻炎中的第2组先天性淋巴细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bb1201369aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302334, encodeId=0a5e130233457, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=World J Gastroenterology：大肠癌患者外周血中单核细胞与淋巴细胞的比率可以作为预后指标, objectType=article, longId=200894, objectId=fea620089499, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fea620089499, replyNumber=0, likeNumber=95, createdTime=2020-09-20, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fea620089499, moduleTitle=World J Gastroenterology：大肠癌患者外周血中单核细胞与淋巴细胞的比率可以作为预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fea620089499)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302333, encodeId=48e21302333ca, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=亚盛医药Bcl-2抑制剂再获FDA孤儿药资格认定，治疗慢性淋巴细胞白血病, objectType=article, longId=200423, objectId=5feb2004238f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5feb2004238f, replyNumber=0, likeNumber=64, createdTime=2020-09-09, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5feb2004238f, moduleTitle=亚盛医药Bcl-2抑制剂再获FDA孤儿药资格认定，治疗慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5feb2004238f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302332, encodeId=e35013023321b, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=FDA授予Bcl-2抑制剂APG-2575孤儿药资格，用于治疗慢性淋巴细胞性白血病, objectType=article, longId=200404, objectId=d860200404a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d860200404a6, replyNumber=0, likeNumber=54, createdTime=2020-09-09, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d860200404a6, moduleTitle=FDA授予Bcl-2抑制剂APG-2575孤儿药资格，用于治疗慢性淋巴细胞性白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d860200404a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302331, encodeId=f2931302331bc, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Leuk Res：伊诺珠单抗治疗复发/难治性急性淋巴细胞白血病患者最小残留疾病的效果, objectType=article, longId=199437, objectId=1a9d19943e0e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a9d19943e0e, replyNumber=0, likeNumber=84, createdTime=2020-08-15, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a9d19943e0e, moduleTitle=Leuk Res：伊诺珠单抗治疗复发/难治性急性淋巴细胞白血病患者最小残留疾病的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a9d19943e0e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302330, encodeId=71de13023308e, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：ETV6介导性儿童急性淋巴细胞白血病易感性的分子基础, objectType=article, longId=198721, objectId=7089198e216c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7089198e216c, replyNumber=0, likeNumber=68, createdTime=2020-08-06, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7089198e216c, moduleTitle=Blood：ETV6介导性儿童急性淋巴细胞白血病易感性的分子基础, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7089198e216c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302329, encodeId=9e571302329fc, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=汇总：基于自体肿瘤浸润淋巴细胞（TIL）的免疫疗法研究进展, objectType=article, longId=198561, objectId=827f198561e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=827f198561e6, replyNumber=0, likeNumber=84, createdTime=2020-08-03, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=827f198561e6, moduleTitle=汇总：基于自体肿瘤浸润淋巴细胞（TIL）的免疫疗法研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=827f198561e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302328, encodeId=abe713023281f, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Cell Reports |：郭晓欢组发现天然与获得性淋巴细胞相互作用新机制, objectType=article, longId=198140, objectId=17711981402b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17711981402b, replyNumber=0, likeNumber=101, createdTime=2020-07-29, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17711981402b, moduleTitle=Cell Reports |：郭晓欢组发现天然与获得性淋巴细胞相互作用新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17711981402b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302327, encodeId=855a130232e1f, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：急性淋巴细胞白血病的风险分层适应性疗法, objectType=article, longId=197648, objectId=5c1419e648ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c1419e648ca, replyNumber=0, likeNumber=66, createdTime=2020-07-18, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c1419e648ca, moduleTitle=Blood：急性淋巴细胞白血病的风险分层适应性疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c1419e648ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞

2020-05-29

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Br J Cancer：放疗前中性粒细胞淋巴细胞比值（NLR）：口咽癌患者的预后指标

2020-10-25

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

达沙替尼-博纳吐单抗治疗成人ph+急性淋巴细胞白血病

2020-10-25

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

NEJM：达沙替尼-博纳吐单抗治疗费城染色体阳性急性淋巴细胞白血病

2020-10-24

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

CD20单抗Ublituximab与PI3K抑制剂Umbralisib联合治疗慢性淋巴细胞白血病，获FDA快速通道指定

2020-10-24

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：奥英妥珠单抗（InO）治疗儿童复发性/难治性CD22阳性急性淋巴细胞白血病

2020-10-22

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：急性淋巴细胞白血病婴儿的风险分层治疗

2020-10-19

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Brit J Cancer：放疗前中性粒细胞与淋巴细胞比率对口咽癌患者的预后意义

2020-10-16

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：家族性B细胞前体-急性淋巴细胞白血病的胚系PAX5突变

2020-10-12

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：慢性淋巴细胞白血病刻板化亚型之间的高阶联系

2020-10-06

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

IBD:中性粒细胞与淋巴细胞之比和血小板与淋巴细胞之比可以预测溃疡性结肠炎患者接受抗TNF治疗后黏膜是否愈合

2020-10-04

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

J Clin Oncol：优化成人急性淋巴细胞白血病患者的嵌合抗原受体T细胞治疗

2020-10-02

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Eur J Pharmacol：miR-155的上调能够调控过敏性鼻炎中的第2组先天性淋巴细胞

2020-09-30

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

World J Gastroenterology：大肠癌患者外周血中单核细胞与淋巴细胞的比率可以作为预后指标

2020-09-20

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

亚盛医药Bcl-2抑制剂再获FDA孤儿药资格认定，治疗慢性淋巴细胞白血病

2020-09-09

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

FDA授予Bcl-2抑制剂APG-2575孤儿药资格，用于治疗慢性淋巴细胞性白血病

2020-09-09

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Leuk Res：伊诺珠单抗治疗复发/难治性急性淋巴细胞白血病患者最小残留疾病的效果

2020-08-15

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：ETV6介导性儿童急性淋巴细胞白血病易感性的分子基础

2020-08-06

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

汇总：基于自体肿瘤浸润淋巴细胞（TIL）的免疫疗法研究进展

2020-08-03

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Cell Reports |：郭晓欢组发现天然与获得性淋巴细胞相互作用新机制

2020-07-29

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：急性淋巴细胞白血病的风险分层适应性疗法

2020-07-18

科室
- - 订阅+
  - 更多科室
工具
服务